Scholars Central

Conference abstractPublished 26 May 2025

Rocuronium and succinylcholine outcomes in rapid sequence in the emergency department in pediatric patients

Authors: Donna Mendez, Zatarain J, Jehle D

University of Texas Medical Branch at Galveston, Texas

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Background: neuromuscular blocking agents used as paralytics in the emergency department (ED) during rapid sequence intubation (RSI). While several prior studies in the past have compared these drugs in adults, very few have been conducted determining which agent is preferred for children. This study analyzed outcomes of death, posttraumatic disorder (PTSD) and malignant hyperthermia for children administered succinylcholine versus rocuronium for RSI in the ED. Methods: This retrospective, propensity matched study utilized the TriNetX database, which provides deidentified electronic medical records of over 110 million patients from 66 health care organizations across the United States. Cohorts included children less than or equal to 17 years of age, given etomidate and ketamine during intubation in the ED from 2004 to 2024. Cohorts were further stratified by the administration of succinylcholine or rocuronium. The outcomes measured were death and post-traumatic stress disorder (PTSD). Propensity matching was done for age, sex, ethnicity/race, and several pre-existing conditions associated with mortality. Results: Before propensity matching 1,151 pediatric patients were identified. After propensity matching 744 patients were identified in each cohort. After propensity matching, children administered succinylcholine had 31% less risk of death (6.1% vs 8.7%, RR 0.693, 95% CI [0.309-1.48], p = 0.048) but no significant difference in risk of PTSD (2.1% vs 3.2%, RR 0.64, 95% CI [0.320-1.600], p = 0.319) but trended to significance for the rocuronium group. Outcomes were similar before propensity matching. There was no significant difference in malignant hyperthermia Conclusions: There was a significant decrease in risk for mortality in children administered succinylcholine for RSI when compared to rocuronium. These findings suggest that when compared to rocuronium, succinylcholine may be a safer paralytic agent for RSI in the ED when there are no contraindications.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalPediatrics & Therapeutics
  • SubjectPaediatrics & Neonatology
  • BylineArticles whose byline prints “Donna Mendez”
  • BylineArticles whose byline prints “Zatarain J”
  • BylineArticles whose byline prints “Jehle D”